+987.9%
MRNA vs PEG
-6.2%
+994.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PEG | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +0.6% | +12.5% | +13.2% |
| 7D | +20.6% | +1.0% | +19.6% | +20.8% |
| 30D | +27.1% | +6.6% | +20.5% | +28.2% |
| 3M | +353.4% | -3.1% | +356.5% | +361.7% |
| 6M | +446.3% | -7.4% | +453.6% | +464.7% |
| YTD | +776.2% | -6.4% | +782.6% | +796.3% |
| 1Y | +987.9% | -7.4% | +995.4% | +1,039.6% |
| All | +987.9% | -6.2% | +994.1% | +1,039.6% |
Cumulative growth
Daily Returns
Daily percentage return beside PEG.
Daily Out/Under-Performance
Portfolio return minus PEG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PEG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PEG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling